News
-
-
PRESS RELEASE
LR Health & Beauty SE bestätigt Wachstumstrend im zweiten Quartal 2024
LR Health & Beauty SE reports 2.6% sales growth, EUR 143.3 million in revenue, and new product launches in H1 2024, despite challenges. EBITDA at EUR 14.4 million. Future plans include IT expansion and product segment launch -
-
-
-
-
-
PRESS RELEASE
LR Health & Beauty SE: Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy
LR Health & Beauty SE attracts major investor Evoco with additional capital from Quadriga Capital to fund successful growth strategy. New Bond 2024/2028 settled